Skip to content
Lower risk Drug recall · FDA · Published August 1, 2018

American Health Packaging Doxycycline Tablets Recall: Failed Dissolution Test

American Health Packaging recalls 100mg Doxycycline Hyclate Tablets due to failed dissolution test. These prescription-only tablets may not release medication properly. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-1582-2019DrugAmerican Health Packaging ›
Take action

Contact the company

Recalling firmAmerican Health Packaging2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

American Health Packaging is recalling prescription doxycycline hyclate tablets that failed dissolution testing. This means the medication might not release properly in the body, potentially reducing effectiveness. Read more at govinfonow.com/recall/39834-american-health-packaging-doxycycline-tablets-recall-failed-dissolution-test.

Source Summary by GovInfoNow · govinfonow.com/recall/39834-american-health-packaging-doxycycline-tablets-recall-failed-dissolution-test · Updated October 6, 2026 · FDA enforcement record: FDA #D-1582-2019

Cite this page

“American Health Packaging Doxycycline Tablets Recall: Failed Dissolution Test.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39834-american-health-packaging-doxycycline-tablets-recall-failed-dissolution-test. Based on FDA recall #D-1582-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1582-2019%22&limit=1).

The FDA announced on August 1, 2018, that American Health Packaging voluntarily recalled Doxycycline Hyclate Tablets due to failed dissolution specifications. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: American Health Packaging
  • Product: Doxycycline Hyclate Tablets, USP, 100 mg
  • Packaging: 30 Tablets per carton (3 x 10 Unit Dose Blisters)
  • NDC Carton: 62584-693-21
  • NDC Unit Dose: 62584-693-11
  • Lot Code: 172569
  • Expiration Date: 7/31/2019

The hazard

The recall was initiated because the product showed out-of-specification results for the dissolution test. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show American Health Packaging has 41 other recalls on record since July 23, 2012. Recent brand recalls include a Buprenorphine Tablets recall for label mix-up hazards on August 19, 2026, and a Nitrofurantoin Capsules recall for dissolution failure risk on May 3, 2022. Other recent recalls of similar products include Ascend Minocycline Tablets Recall (June 1, 2026) and Golden State NIACIN Extended-Release Tablets Recall (May 29, 2026).

How to tell if you have this one

Check for the NDC carton number 62584-693-21 or unit dose number 62584-693-11 on the packaging. The tablets are prescription-only and were distributed by American Health Packaging.

  • Brand
    American Health Packaging
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC carton number 62584-693-21 or unit dose number 62584-693-11 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: Aug 1, 201812. FDA classified it Class II: Jul 31, 201923. Published in FDA’s Enforcement Report: Aug 7, 201934. FDA terminated the recall: Sep 30, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other American Health Packaging recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1582-2019 (August 1, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1582-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA